Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Xiaohongshu shifts investment focus from beauty toward AI

AI summary

TMTPost reports that Xiaohongshu has largely paused beauty-sector investing while accelerating AI-related deals, including a reported $1 billion Series A investment in Moonshot AI and three rounds of backing for AI e-paper company Yuexingtong. The article contrasts this shift with L’Oréal China’s continued industrial investment in beauty and technology companies, including a completed investment in recombinant mussel mucin developer Baiyin Biotechnology. It argues that capital in Chinese consumer technology is increasingly favoring companies with technical differentiation over growth based mainly on social-media exposure.

In-depth insight

Xiaohongshu’s reported pivot from beauty investments to AI and hardware shows a major consumer platform redirecting capital toward frontier technology, while L’Oréal continues deploying funds across beauty supply chains and emerging technologies.

(本文作者为 看见美业,钛媒体经授权发布)

文 | 看见美业,作者 | 此间少年,编辑 | 卢旭成

“欧莱雅在寻找创新机会时,会重点挖掘消费者未被满足的需求与潜在市场空间,再匹配能够承接这些需求的前沿技术,在需求与技术的交叉点上完成布局。”欧莱雅CEO Nicolas Hieronimus表示。

落地到现实则是,日前欧莱雅中国旗下上海美次方投资有限公司,完成对深圳市“潜在独角兽企业”、深耕重组贻贝粘蛋白赛道的深圳柏垠生物科技有限公司的投资。工商信息显示,美次方对柏垠生物持股比例为7.133109%,对应注册资本认缴出资额13.6209万元,该金额并非实际投资总额。

除柏垠生物外,今年以来,欧莱雅通过旗下美次方,以及出资设立的凯辉创美未来、天图美丽领航等多支产业基金,先后完成对多家企业的投资:全周期头皮护理解决方案提供商可氏利夫、AI具身理疗机器人企业德壹医疗、再生医美材料企业摩漾生物、功效型底妆品牌蒂洛薇、氢分子抗衰新材料技术创新平台奇麟正维。其中,凯辉创美未来投资蒂洛薇的当月,蒂洛薇便登上抖音彩妆类目TOP1。

#Xiaohongshu#L’Oréal China#Shanghai Meicifang Investment#Baiyin Biotechnology#Moonshot AI#Yuexingtong#ByteDance#Kuaishou#TILOVY#Moyo Biotechnology

Original · 12 min readRead the original
Group chat

No comments yet. Start the conversation.